NCT05036681 2026-03-27
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
Clinical Trials
41 trialsNCT05082025 2026-01-09
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT05454358 2025-12-15
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
Fudan University
Phase 2/3 Terminated
NCT05263492 2025-10-02
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Virginia Commonwealth University
Phase 2 Terminated
NCT04159155 2025-08-12
CAN-STAMP
University Health Network, Toronto
Phase 2/3 Terminated
NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NCT04527900 2025-06-19
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
University of Maryland, Baltimore
Phase 2 Terminated
NCT03277482 2025-05-31
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT05396794 2025-05-15
SCC-BAREDU
University of Oklahoma
Terminated
NCT04514692 2025-04-23
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
Stanford University
Phase 1/2 Terminated
NCT05523440 2025-03-28
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation
University of Oklahoma
Phase 2 Terminated
NCT04750941 2025-03-04
Study of Copanlisib and Ketogenic Diet
Columbia University
Phase 2 Terminated
NCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03099499 2024-12-24
Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
Fox Chase Cancer Center
Phase 2 Terminated
NCT05877404 2024-04-19
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
Wake Forest University Health Sciences
Terminated
NCT04743999 2024-03-29
Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma
Henry Ford Health System
Phase 2 Terminated
NCT04970368 2024-01-05
Comparison of Nodal Staging in Endometrial Cancer
University of Kentucky
Phase 3 Terminated
NCT03694834 2023-11-28
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT05332483 2023-11-03
MA-EEC
Sunnybrook Health Sciences Centre
Phase 1 Terminated
NCT04511026 2023-10-11
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
Stanford University
Phase 2 Terminated
NCT03642990 2023-04-12
NR in Chemo-induced Peripheral Neuropathy
University of Iowa
Phase 2 Terminated
NCT03924245 2022-04-04
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
Vanderbilt-Ingram Cancer Center
Phase 1 Terminated
NCT03324958 2022-02-08
Vire-Brachy
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Terminated
NCT03572478 2021-03-09
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
University of Chicago
Phase 1/2 Terminated
NCT01939028 2020-08-27
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Case Comprehensive Cancer Center
Phase NA Terminated
NCT02665962 2020-03-10
Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT03466034 2020-01-29
The Role of Hypoxia as a Selective Pressure for TP53 Mutations
Institute of Cancer Research, United Kingdom
Terminated
NCT00394602 2020-01-02
Chemoradiation-Induced Nausea and Emesis: Quality of Life
M.D. Anderson Cancer Center
Terminated
NCT02566811 2019-09-30
STATEC
University College, London
Phase NA Terminated
NCT02907073 2019-05-17
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
Mayo Clinic
Phase 1/2 Terminated
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT02589366 2018-10-15
Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
University of California, San Diego
Phase 1 Terminated
NCT02765698 2018-03-27
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
Mayo Clinic
Terminated
NCT00375804 2018-01-09
Racial Disparity in Endometrial Cancer
University of Louisville
Terminated
NCT01641497 2017-07-21
TOMOGYN
Centre Oscar Lambret
Phase NA Terminated
NCT01184053 2017-06-14
NRR
UNC Lineberger Comprehensive Cancer Center
Phase 2 Terminated
NCT00671606 2016-05-27
Hysteroscopic Lymphatic Mapping for Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01401829 2015-05-12
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
University of Alabama at Birmingham
Phase 1 Terminated
NCT00470067 2014-08-22
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00936598 2014-04-24
Sleep and Endometrial Cancer
University of Pittsburgh
Phase NA Terminated
NCT00161226 2009-12-11
A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
Rutgers, The State University of New Jersey
Terminated